| 14.00 | Welcome and overview of WIPO activities - Mr. Francis Gurry, Deputy Director General
|
| 14.10 | Review of bioethics and intellectual property issues - Mr. Anthony Taubman, Global IP Issues Division, WIPO [PPT]
|
| 14.30 | Perspectives of the European Patent Office (EPO) on bioethics and patent law and practice - Ms. Maria Fotaki, Director, Biotechnology Directorate, EPO [PDF]
|
| 15.00 | Addressing bioethics issues in patent law reform - Mr. Felix Addor, Deputy Director General, Swiss Federal Institute of Intellectual Property [PPT]
|
| 15.30 | Coffee Break |
| 16.00 | Bioethics and commercial research and development in the life sciences - Mr. Peter R. Thomson, Manager Global IP Litigation & Transaction, Corporate Intellectual Property, Novartis [PPT]
- Ms. Karin Blumer, Senior Policy Advisor, Global Public Affairs, Novartis [PPT]
|
| 16.30 | Bioethics and the intellectual property system: a civil society perspective - Ms. Julie Morgan, Asia Pacific Program Coordinator, Franciscans International [PDF]
|
| 17.15 - 17.45 | General discussion |
| 17.45 | Closing |
